Compare · head to head
Fujifilm vs Samsung Biologics
Samsung Biologics ranks higher overall — 360 rank 90 vs 22.
Fujifilm leads on Value (48 vs 36). Samsung Biologics leads on Quality (65 vs 34), Growth (74 vs 38) and Safety (64 vs 46). The two are close on Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Japan | South Korea |
| Sector | Chips & Hardware | Health Care |
| Industry | Technology Hardware, Storage & Peripherals | Life Sciences Tools & Services |
| Size | XX-Large | Small |
| ISIN | JP3814000000 | KR7207940008 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 22 | 90 |
| Value | 48 | 36 |
| Quality | 34 | 65 |
| Growth | 38 | 74 |
| Safety | 46 | 64 |
| Sentiment | 52 | 56 |
| Quality details | ||
| Profitability | 35 | 87 |
| Cash Truth | 34 | 43 |
Fujifilm vs RicohFujifilm vs CanonFujifilm vs Konica MinoltaFujifilm vs Seiko EpsonAdd a third stock →
Full analyses: Fujifilm · Samsung Biologics
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100